Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.570
-0.100 (-3.75%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
185.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 146.07M |
| Protalix BioTherapeutics | 52.74M |
| Precision BioSciences | 34.26M |
| Tonix Pharmaceuticals Holding | 13.11M |
| Whitehawk Therapeutics | 7.15M |
| Korro Bio | 6.39M |
| Cartesian Therapeutics | 2.80M |
ABOS News
- 4 weeks ago - Acumen Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 5 weeks ago - Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio - GlobeNewsWire
- 6 weeks ago - Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 5 months ago - Acumen Pharmaceuticals Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Acumen Pharmaceuticals Transcript: Stifel 2025 Healthcare Conference - Transcripts